Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride–induced cirrhosis
暂无分享,去创建一个
J. Vinel | P. Calès | B. Pipy | J. Pascal | P. Badia | Hervé Desmorat | Omar Lahlou | Jean‐Marc Combis | Marie‐Claude Souqual
[1] J. Vinel,et al. Hemodynamic evaluation of molsidomine: A vasodilator with antianginal properties in patients with alcoholic cirrhosis , 1990, Hepatology.
[2] C. Mélot,et al. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension. , 1989, Journal of hepatology.
[3] M. Navasa,et al. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. , 1989, Gastroenterology.
[4] J. Villeneuve,et al. Intrahepatic Circulation in Liver Disease1 , 1986, Seminars in liver disease.
[5] R. Groszmann,et al. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. , 1986, Gastroenterology.
[6] P. Hayes,et al. The influence of captopril, the nitrates and propranolol on apparent liver blood flow. , 1985, British journal of clinical pharmacology.
[7] A. Blei,et al. Portal-systemic shunting and the hemodynamic effects of nitroglycerin in the rat. , 1984, Gastroenterology.
[8] K. Chatamra,et al. High yield micronodular cirrhosis in the rat. , 1982, Gastroenterology.
[9] D. Lebrec,et al. Changes in splanchnic blood flow in portal hypertensive rats , 1982, European journal of clinical investigation.
[10] P. Pizcueta,et al. Effects of molsidomine. A long-acting venous dilator, on hepatic haemodynamics in patients with cirrhosis and portal hypertension , 1989 .
[11] R. Groszmann,et al. Organic nitrates in portal hypertension. , 1988, European heart journal.
[12] A. Gatta,et al. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. , 1987, Journal of hepatology.
[13] A. Blei,et al. Isosorbide dinitrate in experimental portal hypertension: A study of factors that modulate the hemodynamic response , 1986, Hepatology.
[14] Z. Suzuoki,et al. Biotransformation of Molsidomine (N-Ethoxycarbonyl-3-morpholinosydnonimine), a New Anti-anginal Agent, in Rats , 1974 .